Remifentanil Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Remifentanil Hydrochloride Injection (injection) from Mylan Institutional, a Viatris Company with status Current. The shortage was first posted on 06/28/2022.
Shortage Details
- Status
- Current
- Company
- Mylan Institutional, a Viatris Company
- Package NDC
- 72078-036-05
- Dosage Form
- Injection
- Presentation
- Ultiva, Injection, 5 mg (NDC 72078-036-05)
- Initial Posting
- 06/28/2022
- Revised Date